Compugen (CGEN) Operating Margin (2009 - 2026)
Compugen (CGEN) posted quarterly Operating Margin of 414.38% for Q1 2026, up 4683.0% year-over-year from 8.66% in Q1 2025, and up 397.86% on a QoQ basis from 83.23% in Q4 2025.
Powered by 
Analysis
Compugen (CGEN) Operating Margin (2009 - 2026) Analysis & Trends
Compugen has reported Operating Margin for 15 years, with the latest figure at 414.38% in Q1 2026.
- Operating Margin for Q1 2026 came in at 414.38%, up 4683.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 43.97% (up 9830.0% YoY), and the FY2025 annual result was 43.05%, up 9649.0% from the prior year.
- Operating Margin improved to 414.38% in Q1 2026, from 83.23% in the prior quarter.
- Over five years, Operating Margin peaked at 414.38% in Q1 2026 and troughed at 2006.28% in Q2 2025.
- A 5-year average of 182.43% and a median of 26.24% in 2024 frame the typical range for Operating Margin.
- The largest YoY upside for Operating Margin was 59194 bps in 2025 against a maximum downside of 170196 bps in 2025.
- A 5-year view of Operating Margin shows it stood at 47.05% in 2022, then jumped by 214 bps to 53.75% in 2023, then plunged by 1046 bps to 508.7% in 2024, then soared by 116 bps to 83.23% in 2025, then jumped by 398 bps to 414.38% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 414.38% in Q1 2026, 83.23% in Q4 2025, and 417.4% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.75% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | -1,032.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,032.71% |
| Mar 31, 2026 | 414.38% |
| Dec 31, 2025 | 83.23% |
| Sep 30, 2025 | -417.40% |
| Jun 30, 2025 | -2,006.28% |
| Mar 31, 2025 | 367.56% |
| Dec 31, 2024 | -508.70% |
| Sep 30, 2024 | 26.24% |
| Jun 30, 2024 | -304.33% |
| Mar 31, 2024 | 331.85% |
| Sep 30, 2018 | -42.72% |
| Mar 31, 2018 | 1.15% |
| Dec 31, 2016 | -16,484.91% |
| Sep 30, 2016 | -11,381.43% |
| Jun 30, 2016 | -1,412.90% |
| Mar 31, 2016 | -9,538.71% |
| Dec 31, 2015 | -8.75% |
| Sep 30, 2015 | -3,019.21% |
| Jun 30, 2015 | -3,117.94% |
| Mar 31, 2015 | -1,232.36% |